In KitV558Δ/+ mouse GIST model, anti-PD1 antibody or anti-PD-L1 antibody alone has no effect on GIST, but it can enhance the antitumor effect of imatinib through increasing the effector function of CD8+ T cells [35]. Here, PDCD1 is linked to gastrointestinal stromal tumor.